UTHR
UNITED THERAPEUTICS Corp
Pharmaceutical Preparations- 売上
- $3.2bn
- 時価総額
- $23.6bn
株価 $525.82 · 100株 5万円
| 期 | 23/12 | 24/12 | 25/12 |
|---|---|---|---|
| 売上 | $2.3bn | $2.9bn | $3.2bn |
| 成長率 | — | 23.6% | 10.6% |
| 総利益 | $2.1bn | $2.6bn | $2.8bn |
| 総利益率 | 88.9% | 89.2% | 87.9% |
| 販管費 | $477m | $710m | $756m |
| 販管費率 | 20.5% | 24.7% | 23.7% |
| 営利 | $1.2bn | $1.4bn | $1.5bn |
| 営利率 | 50.9% | 47.9% | 46.9% |
| 純利益 | $985m | $1.2bn | $1.3bn |
| PBR | 3.9 | 3.7 | 3.3 |
| PSR | 10.1 | 8.2 | 7.4 |
| PGPR | 11.4 | 9.2 | 8.4 |
| PER | 24 | 20 | 18 |
| ﾈｯﾄｷｬｯｼｭ | $1.2bn | $1.7bn | $1.6bn |
| EV/EBITDA | 18.1 | 15.1 | 14.0 |
| Rule of 40 | — | 72% | 58% |
| セールス効率 | — | 214% | 500% |
※Rule of 40は売上成長率＋営業利益率、セールス効率は売上総利益増加÷販管費増加（販管費増のときのみ）